Home › Companies › NovoCure Limited › 2025-2026

NovoCure Limited 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and NovoCure Limited’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.

15Reported items
258Asset managers
3,157Fund votes
2026-06-03Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore NovoCure Limited in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by NovoCure Limited

These tallies are NovoCure Limited’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

NovoCure Limited — official shareholder meeting results, meeting held 2026-06-03
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Asaf Danziger	81,489,609	1,388,512	74,479	--	10,874,130	Majority: yes
Elect Director: William Doyle	80,241,009	2,664,190	47,401	--	10,874,130	Majority: yes
Elect Director: Jeryl Hilleman	81,547,820	1,293,373	111,407	--	10,874,130	Majority: yes
Elect Director: David Hung	80,768,325	2,039,529	144,746	--	10,874,130	Majority: yes
Elect Director: Frank Leonard	82,547,254	356,494	48,852	--	10,874,130	Majority: yes
Elect Director: Kinyip Gabriel Leung	79,455,754	3,370,420	126,426	--	10,874,130	Majority: yes
Elect Director: Martin Madden	81,360,641	1,461,539	130,420	--	10,874,130	Majority: yes
Elect Director: Allyson Ocean	81,178,295	1,666,945	107,360	--	10,874,130	Majority: yes
Elect Director: Timothy Scannell	81,540,531	1,292,301	119,768	--	10,874,130	Majority: yes
Elect Director: Kristin Stafford	81,584,398	1,272,045	96,157	--	10,874,130	Majority: yes
Elect Director: William Vernon	81,349,410	1,483,356	119,834	--	10,874,130	Majority: yes
Proposal 2: Ratification of Independent Registered Public Accounting Firm .	91,436,910	2,337,255	52,565	--	--	Passed
Proposal 3: Approval of a non-binding advisory vote to approve executive compensation .	75,392,168	7,422,876	137,556	--	10,874,130	Passed
Proposal 4: Approval of the Company's Amended and Restated 2024 Omnibus Incentive Plan .	41,680,622	41,161,139	110,839	--	10,874,130	Passed

Source: NovoCure Limited, Form 8-K — read the filing on EDGAR.

How asset managers voted at the NovoCure Limited 2025-2026 meeting

Each item below shows how the 258 asset managers that disclosed a NovoCure Limited vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of NovoCure Limited’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. A non-binding advisory vote to approve executive compensation.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 3 wordings of this item as funds reported it.

91% Passed · of votes cast

FOR 91%9%

FOR: 75,392,168AGAINST: 7,422,876

NovoCure Limited’s own tally for this item (“Proposal 3: Approval of a non-binding advisory vote to approve executive compensation .”): 75,392,168 for, 7,422,876 against — passed, per its Form 8-K (Item 5.07). Of all 115,820,940 outstanding shares: 65% for, 6% against (72% of the company cast a for/against vote).

The 248 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 94%

FOR: 93.8%AGAINST: 6.2%ABSTAIN: 0.0%NOT VOTED: 0.0%

Largest asset managers voting on “A non-binding advisory vote to approve executive compensation.” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Vote
Fidelity	28,325,853	0	For
BlackRock	12,326,137	18,599	For
Vanguard	11,762,453	14,013	For
Soleus Capital Management, L.P.	7,585,209	0	For
WELLS FARGO CLEARING SERVICES, LLC	2,908,813	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,422,298	0	For
State Street	2,161,674	436	For
T. Rowe Price	1,823,904	0	For
Charles Schwab	1,675,834	0	For
Palo Alto Investors LP	1,280,439	0	For
C WorldWide Asset Management Fondsmaeglerselskab A/S	0	971,784	Against
JACOBS LEVY EQUITY MANAGEMENT, INC	956,322	0	For
Nuveen	873,108	0	For
Northern Trust	863,616	0	For
TIAA	861,235	0	For
BAILLIE GIFFORD & CO LTD	727,032	0	For
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	726,400	0	For
Point72	642,669	0	For
BNP Paribas Asset Management Holding S.A.	0	509,642	Against
SILVERCREST ASSET MANAGEMENT GROUP LLC	0	486,467	Against
DE Shaw	431,560	0	For
Dimensional	0	425,609	Against
Renaissance	388,231	0	For
Connor, Clark & Lunn Investment Management Ltd.	372,791	0	For
Putnam	330,766	0	For

Showing the 25 largest of 248 asset managers. See all 248 in the interactive database.

2. THE APPROVAL OF OUR AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN.

COMPENSATIONCompany result: Passed

Combines 2 wordings of this item as funds reported it.

50.3% Passed · of votes cast

FOR 50.3%AGAINST 49.7%

FOR: 41,680,622AGAINST: 41,161,139

NovoCure Limited’s own tally for this item (“Proposal 4: Approval of the Company's Amended and Restated 2024 Omnibus Incentive Plan .”): 41,680,622 for, 41,161,139 against — passed, per its Form 8-K (Item 5.07). Of all 115,820,940 outstanding shares: 36% for, 36% against (72% of the company cast a for/against vote).

The 61 asset managers below cast 40% of the shares they voted on this item FOR (13,495,525 for, 19,929,950 against).

FOR 40%AGAINST 60%

FOR: 13,495,525 (40.4%)AGAINST: 19,929,950 (59.6%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “THE APPROVAL OF OUR AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN.” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	47,150	11,223,363	0	Against
Vanguard	6,257,105	4,636,121	0	For
BlackRock	4,694,305	1,585,752	0	For
TIAA	0	861,235	0	Against
Charles Schwab	837,814	0	0	For
T. Rowe Price	577,298	17,464	0	For
Dimensional	0	299,380	0	Against
Equitable	147,397	90,450	0	For
State Street	176,313	0	0	For
Lincoln Financial	83,096	51,131	0	For
American Century	0	120,517	0	Against
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	0	113,625	0	Against
Eversept Partners, LP	111,640	0	0	For
JPMorgan	100,412	0	0	For
First Trust	0	94,248	0	Against
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	0	69,407	0	Against
1290 Funds	0	64,088	0	Against
DWS	0	63,324	0	Against
AIG/SunAmerica	0	58,296	0	Against
Brighthouse	0	39,049	18,379	Against
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	34,711	20,959	0	For
MASTER INVESTMENT PORTFOLIO	0	53,827	0	Against

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

3. Election of Directors: Allyson Ocean

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,178,295AGAINST: 1,666,945

NovoCure Limited’s own tally for this item (“Elect Director: Allyson Ocean”): 81,178,295 for, 1,666,945 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (33,280,558 for, 4 against).

FOR 99.9%

FOR: 33,280,558 (99.9%)AGAINST: 4 (0.0%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Allyson Ocean” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,893,248	4	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	57,379	0	0	For
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

4. Election of Directors: Asaf Danziger

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,489,609AGAINST: 1,388,512

NovoCure Limited’s own tally for this item (“Elect Director: Asaf Danziger”): 81,489,609 for, 1,388,512 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.6% of the shares they voted on this item FOR (33,164,405 for, 116,157 against).

FOR 99.5%

FOR: 33,164,405 (99.6%)AGAINST: 116,157 (0.3%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Asaf Danziger” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,884,443	8,809	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

5. Election of Directors: David Hung

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 80,768,325AGAINST: 2,039,529

NovoCure Limited’s own tally for this item (“Elect Director: David Hung”): 80,768,325 for, 2,039,529 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 2% against (71% of the company cast a for/against vote).

The 58 asset managers below cast 99.6% of the shares they voted on this item FOR (33,164,404 for, 116,158 against).

FOR 99.5%

FOR: 33,164,404 (99.6%)AGAINST: 116,158 (0.3%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: David Hung” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,884,442	8,810	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

6. Election of Directors: Frank Leonard

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 82,547,254AGAINST: 356,494

NovoCure Limited’s own tally for this item (“Elect Director: Frank Leonard”): 82,547,254 for, 356,494 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 71% for, 0.4% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (33,280,561 for, 1 against).

FOR 99.9%

FOR: 33,280,561 (99.9%)AGAINST: 1 (0.0%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Frank Leonard” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,893,251	1	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	57,379	0	0	For
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

7. Election of Directors: Jeryl Hilleman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,547,820AGAINST: 1,293,373

NovoCure Limited’s own tally for this item (“Elect Director: Jeryl Hilleman”): 81,547,820 for, 1,293,373 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.6% of the shares they voted on this item FOR (33,164,405 for, 116,157 against).

FOR 99.5%

FOR: 33,164,405 (99.6%)AGAINST: 116,157 (0.3%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Jeryl Hilleman” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,884,443	8,809	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

8. Election of Directors: Kinyip Gabriel Leung

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 79,455,754AGAINST: 3,370,420

NovoCure Limited’s own tally for this item (“Elect Director: Kinyip Gabriel Leung”): 79,455,754 for, 3,370,420 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 69% for, 3% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.5% of the shares they voted on this item FOR (33,117,145 for, 163,417 against).

FOR 99.4%

FOR: 33,117,145 (99.5%)AGAINST: 163,417 (0.5%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Kinyip Gabriel Leung” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,879,247	14,005	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	60,427	33,575	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

9. Election of Directors: Kristin Stafford

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,584,398AGAINST: 1,272,045

NovoCure Limited’s own tally for this item (“Elect Director: Kristin Stafford”): 81,584,398 for, 1,272,045 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (33,280,559 for, 3 against).

FOR 99.9%

FOR: 33,280,559 (99.9%)AGAINST: 3 (0.0%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Kristin Stafford” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,893,249	3	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	57,379	0	0	For
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

10. Election of Directors: Martin Madden

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,360,641AGAINST: 1,461,539

NovoCure Limited’s own tally for this item (“Elect Director: Martin Madden”): 81,360,641 for, 1,461,539 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (33,280,559 for, 3 against).

FOR 99.9%

FOR: 33,280,559 (99.9%)AGAINST: 3 (0.0%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Martin Madden” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,893,249	3	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	57,379	0	0	For
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

11. Election of Directors: Timothy Scannell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,540,531AGAINST: 1,292,301

NovoCure Limited’s own tally for this item (“Elect Director: Timothy Scannell”): 81,540,531 for, 1,292,301 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.6% of the shares they voted on this item FOR (33,164,405 for, 116,157 against).

FOR 99.5%

FOR: 33,164,405 (99.6%)AGAINST: 116,157 (0.3%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: Timothy Scannell” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,884,443	8,809	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

12. Election of Directors: William Doyle

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 80,241,009AGAINST: 2,664,190

NovoCure Limited’s own tally for this item (“Elect Director: William Doyle”): 80,241,009 for, 2,664,190 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 69% for, 2% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.5% of the shares they voted on this item FOR (33,125,635 for, 154,927 against).

FOR 99.4%

FOR: 33,125,635 (99.5%)AGAINST: 154,927 (0.5%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: William Doyle” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,879,248	14,004	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	60,427	33,575	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

13. Election of Directors: William Vernon

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 81,349,410AGAINST: 1,483,356

NovoCure Limited’s own tally for this item (“Elect Director: William Vernon”): 81,349,410 for, 1,483,356 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 115,820,940 outstanding shares: 70% for, 1% against (72% of the company cast a for/against vote).

The 58 asset managers below cast 99.6% of the shares they voted on this item FOR (33,164,405 for, 116,157 against).

FOR 99.5%

FOR: 33,164,405 (99.6%)AGAINST: 116,157 (0.3%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “Election of Directors: William Vernon” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,884,443	8,809	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	94,002	0	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

14. THE APPROVAL AND RATIFICATION OF THE APPOINTMENT, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AS THE AUDITOR AND INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE COMPANY'S FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATEDCompany result: Passed

98% Passed · of votes cast

FOR 98%

FOR: 91,436,910AGAINST: 2,337,255

NovoCure Limited’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm .”): 91,436,910 for, 2,337,255 against — passed, per its Form 8-K (Item 5.07). Of all 115,820,940 outstanding shares: 79% for, 2% against (81% of the company cast a for/against vote).

The 57 asset managers below cast 99.5% of the shares they voted on this item FOR (33,097,443 for, 146,119 against).

FOR 99.5%

FOR: 33,097,443 (99.5%)AGAINST: 146,119 (0.4%)ABSTAIN: 18,379 (0.1%)

Largest asset managers voting on “THE APPROVAL AND RATIFICATION OF THE APPOINTMENT, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF KOST FO” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	11,270,513	0	0	For
Vanguard	10,888,056	5,196	0	For
BlackRock	6,280,057	0	0	For
TIAA	861,235	0	0	For
Charles Schwab	837,814	0	0	For
T. Rowe Price	594,762	0	0	For
Dimensional	299,380	0	0	For
Equitable	237,847	0	0	For
State Street	176,313	0	0	For
Lincoln Financial	134,227	0	0	For
American Century	120,517	0	0	For
QUANTITATIVE MASTER SERIES LLC	119,229	0	0	For
Putnam	113,625	0	0	For
JPMorgan	100,412	0	0	For
First Trust	94,248	0	0	For
Global X	60,427	33,575	0	For
EXCHANGE TRADED CONCEPTS TRUST	69,407	0	0	For
1290 Funds	64,088	0	0	For
DWS	63,324	0	0	For
AIG/SunAmerica	58,296	0	0	For
Brighthouse	39,049	0	18,379	For
Amplify ETF Trust	0	57,379	0	Against
Pacific Life	55,670	0	0	For
MASTER INVESTMENT PORTFOLIO	53,827	0	0	For
PACE SELECT ADVISORS TRUST	52,709	0	0	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

15. ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

91% Passed · of votes cast

FOR 91%9%

FOR: 75,392,168AGAINST: 7,422,876

The 8 asset managers below cast 42% of the shares they voted on this item FOR (202,088 for, 279,981 against).

FOR 42%AGAINST 58%

FOR: 202,088 (41.9%)AGAINST: 279,981 (58.1%)

Largest asset managers voting on “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” at NovoCure Limited, 2025-2026
Asset manager	For	Against	Vote
ALGERT GLOBAL LLC	0	260,849	Against
Eversept Partners, LP	111,640	0	For
BlackRock	18,030	18,975	Against
CLEARWATER INVESTMENT TRUST	37,000	0	For
WASHINGTON CAPITAL MANAGEMENT, INC	32,400	0	For
Moment Partners, LLC	3,000	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	157	Against
Wilshire Advisors LLC	18	0	For

Largest NovoCure Limited shareholders voting in 2025-2026

Ranked by the number of NovoCure Limited shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 115,820,940 shares outstanding at the time of that meeting.

Top NovoCure Limited shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	24.46%
2	BlackRock	10.66%
3	Vanguard	10.17%
4	Soleus Capital Management, L.P.	6.55%
5	WELLS FARGO CLEARING SERVICES, LLC	2.51%
6	GEODE CAPITAL MANAGEMENT, LLC	2.09%
7	State Street	1.87%
8	T. Rowe Price	1.57%
9	Charles Schwab	1.45%
10	Palo Alto Investors LP	1.11%

Reported NovoCure Limited ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

NovoCure Limited beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
FMR (Fidelity)	14.74%	13F
BlackRock	11.39%	13F
Vanguard Group	9.46%	13F
Morgan Stanley	4.38%	13F
State Street	2.21%	13F
Geode Capital	2.17%	13F
Renaissance Technologies	1.34%	13F
Point72	1.18%	13F
JPMorgan Chase	0.80%	13F
William Doyle	0.76%	DEF14A

Percentages above are of 115,820,940 shares outstanding, as reported by NovoCure Limited on its Form 10-Q dated 2026-04-24 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NovoCure Limited’s 10-Q dated 2026-04-24. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At NovoCure Limited's shareholder meeting held 2026-06-03, in the 2025-2026 proxy season, 258 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,157 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote to approve executive compensation. — the proposal passed with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NovoCure Limited's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

NovoCure Limited proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).